The Magic of Mushrooms

The big picture: While research continues, psychedelic medicine could reshape the future of healthcare and wellness. As momentum builds, scientists, startups, investors, and big pharma are plotting their next move.

Psychedelic therapies seem to be changing this

Psychedelics-as-a-service. Unlike cannabis, proponents are quick to warn that psychedelics aren’t a commodity, they’re a service. Marijuana is a commodity that can be cultivated and distributed. Psychedelics, on the other hand, rely on delivery — or the service component.

What’s happening: In the 1970s, psychedelics were criminalized, effectively ending research into therapeutic uses. More recently, regulators have eased restrictions on psychedelic research, fast-tracking clinical studies and legitimizing the space.

Psychedelics relax harmful beliefs and open a window for revision (like someone with depression feeling and believing they’re worthless)